Infosys Brokerage: ICICI Direct Rating: Hold Target: Rs 2650 Rationale: It expects revenues, EPS to grow 12%, 6% in FY14E translating to revenue. It now value Infosys at 14.8x its CY14E EPS estimate of Rs 179.4 and raises target price to Rs 2,650 versus Rs 2,450 earlier.
Tata Motors Brokerage: Citi Rating: Buy Target: Rs 344 Rationale: Jaguar land rover's first quarter retail sales grew 10%, driven by jaguar, up more than 30 % year on year, while land rover volume growth was slightly weak. .
Infosys Brokerage: Jefferies Rating: Buy Target: Rs 3250 Rationale: With large deal wins continuing, Jefferies is positive on volume growth and the resultant operating leverage.
Dr Reddy’s Brokerage: Citi Rating: Buy Target: Rs 2,125 Rationale: The approval for Dacogen is positive given the uncertainty over FDA approval timelines & the impact that it can have on street estimates for Dr Reddy's.
Infosys Brokerage: Nomura Rating: Reduce Target: Rs 2,120 Rationale: It feels consensus expectations for revenue growth will be revised upwards and will likely be above the 10% growth guidance.